158 papers found
Refreshing results…
Adoptive T-cell therapy: a need for standard immune monitoring
Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells
Polyfunctional Tumor Antigen-specific T Cells Generated in Vitro from Human CD34 Positive Precursor Cells Transduced to Express T Cell Receptor αβ Chains Fused to CD28-CD3ζ Signaling Cassette
T-cell derived cellular vehicles demonstrate intraparenchymal tropism for infiltrative glioma and effective delivery of Delta24-RGD
T Cell Receptor-Engineered T Cells to Treat Solid Tumors: T Cell Processing Toward Optimal T Cell Fitness
Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment
TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity.
The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity
Locally-Delivered T-Cell-Derived Cellular Vehicles Efficiently Track and Deliver Adenovirus Delta24-RGD to Infiltrating Glioma
TCR-Engineered T cells
The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity
Polyfunctional tumor antigen-specific T cells generated in vitro from human CD34 positive precursor cells transduced to express T cell receptor alpha beta chains fused to CD28-CD3 zeta signaling cassette
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
Figure S1
TCR-engineered T cells: A model of inducible TCR expression to dissect the interrelationship between two TCRs
An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT
Genetically modified T lymphocytes: More than just direct effectors
Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Missing publications? Read more about our data sources.